ストックスクリーナーアプリを入手
0.4215
3.10%
-0.0135
アフターアワーズ：
.43
0.0085
+2.02%
Prophase Labs Inc (PRPH) 最新ニュース
What analysts say about ProPhase Labs Inc. stockDynamic investment growth - PrintWeekIndia
How ProPhase Labs Inc. stock reacts to Fed policy changesTremendous growth opportunities - jammulinksnews.com
ProPhase Labs shares rise 1.15% premarket after closing $3 million senior secured convertible notes financing. - AInvest
ProPhase Labs Announces Closing of $3 Million Senior Secured Convertible Notes Financing - GlobeNewswire
ProPhase Labs secures $3 million in convertible notes financing By Investing.com - Investing.com Canada
ProPhase Labs secures $3 million in convertible notes financing - Investing.com Australia
Prophase Labs Secures $3 Million in Private Financing - TipRanks
ProPhase Labs Raises $3M as Bridge to $50M Covid Collections and Crypto Strategy Launch - Stock Titan
What drives ProPhase Labs Inc. stock priceUnprecedented profits - jammulinksnews.com
ProPhase Labs Board of Directors Authorizes Management to - GlobeNewswire
Why ProPhase Labs Inc. stock attracts strong analyst attentionBreakout Momentum Stocks - Newser
Is ProPhase Labs Inc. a good long term investmentDynamic growth stocks - jammulinksnews.com
ProPhase Labs Inc. Stock Analysis and ForecastUnbelievable profit margins - jammulinksnews.com
Prophase Labs Explores Reverse Merger with Digital Asset Firm - TipRanks
ProPhase Labs explores reverse merger with digital asset company - Investing.com
ProPhase Labs explores strategic reverse merger and approves crypto treasury initiative. - AInvest
ProPhase Labs Board of Directors Authorizes Management to Explore Strategic Reverse Merger and Approves Crypto Treasury Initiative - The Globe and Mail
ProPhase Labs Makes Bold Crypto Move: Plans Reverse Merger While Protecting $50M Healthcare Portfolio - Stock Titan
What makes ProPhase Labs Inc. stock price move sharplyHigh Potential Safe Trades - beatles.ru
Prophase Labs shares rise 1.88% after-hours following an investor presentation. - AInvest
Prophase Labs shares fall 10.58% intraday after investor presentation. - AInvest
How ProPhase Labs Inc. stock performs during market volatilityFree Stock Portfolio Optimization - Newser
ProPhase Labs Regains Nasdaq Compliance with New Appointment - The Globe and Mail
PCSA ends Ocuphire licensing deal, starts portfolio review – Form 8-K - Stock Titan
Prophase Labs Secures $1M in New Loan Agreements - TipRanks
ProPhase Labs, Inc. Receives Additional 180 Day Extension from N - GuruFocus
ProPhase Labs, Inc. Receives Additional 180 Day Extension - GlobeNewswire
ProPhase Labs Given 180-Day Extension by Nasdaq to Regain Compliance With $1 Minimum Bid Price Rule - MarketScreener
Prophase Labs Appoints Carolina Abenante as Director - TipRanks
ProPhase Labs appoints Carolina Abenante as independent director By Investing.com - Investing.com UK
ProPhase Labs, Inc. announced that it expects to receive $0.5 million in funding - MarketScreener
ProPhase Labs Announces Successful Study Demonstrating Performan - GuruFocus
ProPhase Labs (PRPH) Advances with Positive Validation of BE-Smart Test | PRPH Stock News - GuruFocus
Prophase Labs Announces Successful Study Demonstrating Performance Of Be-Smart(TM) Test In Detecting Esophageal Cancer - MarketScreener
ProPhase Labs Inc. Validates BE-Smart™ Diagnostic Test for Esophageal Disease with Over 95% Success Rate - Nasdaq
ProPhase Labs Announces Successful Study Demonstrating - GlobeNewswire
0.96%
大文字化:
|
ボリューム (24 時間):